Aptevo Therapeutics (APVO)
(Real Time Quote from BATS)
$0.68 USD
0.00 (-0.38%)
Updated Apr 25, 2024 09:50 AM ET
2-Buy of 5 2
C Value F Growth A Momentum D VGM
Cash flow Statements
Fiscal Year End for Aptevo Therapeutics Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -17.41 | 8.03 | -28.46 | -17.75 | 0.00 |
Depreciation/Amortization & Depletion | 0.57 | 0.90 | 1.14 | 1.41 | 0.00 |
Net Change from Assets/Liabilities | 2.91 | 2.14 | -2.66 | -2.41 | 0.00 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 2.20 | -32.09 | 8.29 | -10.57 | 0.00 |
Net Cash From Operating Activities | -11.73 | -21.02 | -21.68 | -29.32 | 0.00 |
Property & Equipment | 0.00 | -0.03 | -0.71 | -0.09 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 28.12 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 0.00 | -0.03 | -0.71 | 28.03 | 0.00 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 9.48 | 6.93 | 11.44 | 0.02 | 0.00 |
Issuance (Repayment) of Debt | -3.47 | -12.27 | -10.55 | 2.63 | -137.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.01 | 2.72 | 25.27 | 21.22 | 0.00 |
Net Cash from Financing Activities | 6.00 | -2.62 | 26.16 | 23.87 | -137.00 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -5.73 | -23.67 | 3.77 | 22.59 | -137.00 |
Cash at Beginning of Period | 22.64 | 46.30 | 42.53 | 19.95 | 0.00 |
Cash at End of Period | 16.90 | 22.64 | 46.30 | 42.53 | 0.00 |
Diluted Net EPS | -62.56 | 69.16 | -267.40 | -230.40 | -610.82 |
Fiscal Year End for Aptevo Therapeutics Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -17.41 | -11.51 | -5.18 | 2.77 |
Depreciation/Amortization & Depletion | NA | 0.57 | 0.45 | 0.33 | 0.18 |
Net Change from Assets/Liabilities | NA | 2.91 | 2.74 | 3.22 | 0.69 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 2.20 | 1.85 | 1.39 | 0.93 |
Net Cash From Operating Activities | NA | -11.73 | -6.48 | -0.24 | 4.57 |
Property & Equipment | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 9.48 | 3.28 | 2.08 | 1.60 |
Issuance (Repayment) of Debt | NA | -3.47 | -3.47 | -3.47 | -3.47 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -0.01 | 3.14 | -0.01 | -0.01 |
Net Cash from Financing Activities | NA | 6.00 | 2.95 | -1.39 | -1.87 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -5.73 | -3.53 | -1.63 | 2.69 |
Cash at Beginning of Period | NA | 22.64 | 22.64 | 22.64 | 22.64 |
Cash at End of Period | NA | 16.90 | 19.11 | 21.01 | 25.33 |
Diluted Net EPS | NA | -3.52 | -22.03 | -54.19 | 17.18 |